TVRD

Tvardi Therapeutics INC

-$3.6M

Net Activity

Institutions Holding

67

Popularity Rank

#5317

Avg Weight

0.01%

Total Value

$8.6M

Ownership Trend

67 institutions currently hold TVRD, with 32 net buyers and 30 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

30

Net Buying Institutions

32

Key Holders

View all 67 holding institutions

Quarterly Activity

Recent Activity

+$1.3M

Total Buy Value

$4.6M

Total Sell Value

New buy13
Trim17
Add19
Sold out13

32

Net Buyers

30

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-07

View all Form 8-K filings

FAQ

Who are the top institutional investors holding TVARDI THERAPEUTICS INC (TVRD)?
Major stakeholders currently include Slate Path Capital LP ($2.2M), BlackRock, Inc. ($1.2M), Vanguard Capital Management LLC ($1.1M). Based on the latest 13F filings, there are a total of 67 tracked investment funds and institutions maintaining positions in TVRD.
What is the overall institutional sentiment toward TVRD recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $3.6M, driven by 32 managers accumulating shares while 30 reduced their exposure.
Which institutions have been selling or reducing their TVRD positions?
In the latest period, 17 funds trimmed their holdings, and 13 managers completely exited their positions. The aggregate reported sell value was $4.6M.
Are there any notable investors adding TVRD to their portfolios?
Yes, buying activity remains notable. 13 institutions opened new positions in {ticker}, and 19 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.3M.

Related Stocks